How much of wrap Technologies'stock are insiders selling?
In the past three months, Wrap Technologies insiders have sold 256.45% more of their company's stock than they have bought. Specifically, they have bought $24,475.00 in company stock and sold $87,240.00 in company stock. 43.00% of the stock of Wrap Technologies is held by insiders.
Is resapp health (Ras) a good stock to buy?
ResApp Health has received 71.43% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about ResApp Health and other stocks.
What is wrap technologies'(wrap) stock price potential next year?
Their forecasts range from $6.75 to $10.00. On average, they expect Wrap Technologies' stock price to reach $8.38 in the next year. This suggests a possible upside of 251.9% from the stock's current price.
Where can I buy shares of wrap?
Shares of WRAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Who are ResApp Health's key executives?
ResApp Health's management team includes the following people: Dr. Anthony Keating , CEO, MD & Director Mr. Brian Leedman B.Econ. , BECON, M.B.A...
Who are some of ResApp Health's key competitors?
Some companies that are related to ResApp Health include 1st Group (1ST) , Alcidion Group (ALC) , Artrya (AYA) , Binovi Technologies (BNVIF) ,...
What is ResApp Health's stock symbol?
ResApp Health trades on the ASX under the ticker symbol "RAP."
How much money does ResApp Health make?
ResApp Health has a market capitalization of $0.00 and generates $104.43 thousand in revenue each year.
How many employees does ResApp Health have?
ResApp Health employs 500 workers across the globe.
What is ResApp Health's official website?
The official website for ResApp Health is www.resapphealth.com.au .
How can I contact ResApp Health?
The company can be reached via phone at 61 7 3724 0035 .
How much money does ResApp Health make?
What is ResApp Health?
ResApp Health has a market capitalization of $0.00 and generates $69.73 thousand in revenue each year .
Is there enough data for ResApp Health?
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a direct-to-consumer smartphone application for the self-assessment of sleep apnoea in 36 countries. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.
Does ResApp pay dividends?
There is not enough analysis data for ResApp Health.
